Filing
Spy
Filing
Spy
Home
About
NBSE
Neubase Therapeutics Inc
Biotechnology company
CUSIP: 64132K102
Healthcare
US
1 holder
Ownership
Activity
2020 Q4
10 of 15 quarters
Total Value
$14.17M
Total Shares
2.03M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Greenlight Capital
$14.17M
2.03M
0.9%
Unchanged
Greenlight Capital
$14.17M
2.03M shares
Unchanged
NBSE — Neubase Therapeutics Inc - FilingSpy